1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Anuh Pharma Limited

Anuh Pharma Limited

ANUHPHR.BO
Anuh Pharma LimitedIN flagBombay Stock Exchange
77.38
INR
-1.55
- -
7.76BMarket Cap

Total Valuation

Anuh Pharma Limited carries a market capitalization of 7.76B, placing it among publicly traded companies globally. Its enterprise value stands at 6.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap7.76B
Enterprise Value6.18B

Share Statistics

Anuh Pharma Limited currently has 100.22M shares outstanding.

Shares Outstanding100.22M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Anuh Pharma Limited trades at a trailing price-to-earnings ratio of 16.37. The price-to-sales ratio is 0.87, and the price-to-book ratio stands at 13.41.

PE Ratio16.37
PS Ratio0.87
PB Ratio13.41
P/TBV Ratio1.91
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Anuh Pharma Limited trades at an EV/EBITDA multiple of 13.01 and an EV/FCF ratio of 1,728.02. The EV/Sales ratio of 0.80 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.01 provides insight into valuation relative to core operating earnings.

EV / Sales0.80
EV / EBITDA13.01
EV / EBIT13.01
EV / FCF1,728.02

Financial Position

Anuh Pharma Limited maintains a current ratio of 2.22, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.02, indicating conservative leverage, while an interest coverage ratio of 100.51 demonstrates strong ability to service its debt obligations.

Current Ratio2.22
Quick Ratio0.27
Debt / Equity0.02
Debt / EBITDA0.00
Interest Coverage100.51

Financial Efficiency

Anuh Pharma Limited posts a return on equity of 31.62 and a return on invested capital of 10.38.

Return on Equity (ROE)31.62
Return on Assets (ROA)7.72
Return on Invested Capital (ROIC)10.38
Return on Capital Employed (ROCE)30.61
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.40

Taxes

Over the trailing twelve months, Anuh Pharma Limited has paid 131.75M in income taxes, reflecting an effective tax rate of 24.30.

Income Tax131.75M
Effective Tax Rate24.30

Stock Price Statistics

Anuh Pharma Limited's stock has declined approximately -29.92846% over the past 52 weeks. The 50-day moving average sits at 79.03, while the 200-day moving average is 79.04.

Beta (5Y)N/A
52-Week Price Change-29.92846%
50-Day Moving Average79.03
200-Day Moving Average79.04
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Anuh Pharma Limited generated 7.72B in revenue and converted that into 410.46M in net income, yielding earnings per share of 4.10. EBITDA reached 474.72M, while operating income came in at 474.72M.

Revenue7.72B
Gross Profit1.72B
Operating Income474.72M
Pretax Income542.21M
Net Income410.46M
EBITDA474.72M
EBIT474.72M
Earnings Per Share (EPS)4.10

Balance Sheet

Anuh Pharma Limited holds 541.02M in cash and equivalents against 583,000.00 in total debt, resulting in a net debt position of -80.60M. Total book value stands at 501.12M, with working capital of 2.48B providing operational flexibility.

Cash & Cash Equivalents541.02M
Total Debt583,000.00
Net Debt-80.60M
Equity (Book Value)501.12M
Book Value Per Share5.01
Working Capital2.48B

Margins

Anuh Pharma Limited operates with a gross margin of 22.29, reflecting its pricing power and cost economics. The operating margin of 6.15 and net profit margin of 5.32 provide insight into operational efficiency.

Gross Margin22.29
Operating Margin6.15
Pretax Margin7.03
Profit Margin5.32
EBITDA Margin6.15

Stock Splits

Anuh Pharma Limited's most recent stock split took place on July 15, 2025 with a 1:2 split ratio.

Last Split Date7/15/2025
Split Ratio1:2

Scores

Anuh Pharma Limited posts an Altman Z-Score of 4.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.17